Skip to main content

HubXchange

HubXChange logo

Immunotherapies Xchange - Brussels - 2024

Page Banner 1

  1. Translational Immunology
    • Translational Immunology
    Role of combination therapies in improving immunotherapy efficacy
    New developments in the field of combination cancer therapy. Is monotherapy efficacy always essentia ...
    Nicholas Glanville
    Nicholas Glanville, Vice President of Research - Prokarium
    • Immunogenicity
    • Immune Regulation
    • Translational Immunology
    • Clinical Development
    Evening Drinks Reception
    • Immunogenicity
    • Immune Regulation
    • Translational Immunology
    • Clinical Development
    1-2-1 Meetings / Networking Break
    • Immunogenicity
    • Immune Regulation
    • Translational Immunology
    • Clinical Development
    1-2-1 Meetings / Networking Break
    • Immunogenicity
    • Immune Regulation
    • Translational Immunology
    • Clinical Development
    Spotlight Presentation
    • Immunogenicity
    • Immune Regulation
    • Translational Immunology
    • Clinical Development
    Networking Lunch
  7. Translational Immunology
    • Translational Immunology
    Early-stage Characterization and Selection of Immuno-Oncology Drug Candidates in Customized In Vitro Assays
    Early-stage Characterization and Selection of Immuno-Oncology Drug Candidates in Customized In Vitro Assays
    From checkpoint inhibitors towards therapeutic vaccines, does one size fits it all? Fit for purpose  ...
    Christoph Schifflers
    Christoph Schifflers, Scientist Immuno-oncology - IQVIA Laboratories – In Vitro Immunology
  8. Immunogenicity
    • Immunogenicity
    Sponsor Led Roundtable Discussion
    • Immunogenicity
    • Immune Regulation
    • Translational Immunology
    • Clinical Development
    Morning Refreshments
    • Immunogenicity
    • Immune Regulation
    • Translational Immunology
    • Clinical Development
    1-2-1 Meetings / Networking Break
    • Immunogenicity
    • Immune Regulation
    • Translational Immunology
    • Clinical Development
    1-2-1 Meetings / Networking Break
  12. Immune Regulation
    • Immune Regulation
    Avoiding recurrence of infection and minimising autoimmunity-induced side effects
    Maria Eugenia Alonso Ferrero
    Maria Eugenia Alonso Ferrero, Associate Director, Science Strategy - Alexion Pharmaceuticals
  13. Clinical Development
    • Clinical Development
    Investigating how tumour microenvironment supports immune evasion
    Mo Okily
    Mo Okily, Director, Clinical Development - Immunology - GSK
  14. Translational Immunology
    • Translational Immunology
    Application of multi-omics approaches to dissect immune responses and identify disease-associated biomarkers
    Mustafa Diken
    Mustafa Diken, Vice President Vaccines & Immunology - BioNTech SE
  15. Immunogenicity
    • Immunogenicity
    Assessing risks posed by the innate immune response
    Maria Loustau
    Maria Loustau, R&D Director - Invectys
    • Immunogenicity
    • Immune Regulation
    • Translational Immunology
    • Clinical Development
    Opening Address & Keynote Presentation
    Opening Address & Keynote Presentation
    • Immunogenicity
    • Immune Regulation
    • Translational Immunology
    • Clinical Development
    Registration
Search